Historical salary details - Mr. Tomas Kiselak, Independent Director, Dianthus Therapeutics Inc
Mr. Tomas Kiselak is the Independent Director of Dianthus Therapeutics Inc.
Mr. Tomas Kiselak
Independent Director
-
Gross Remuneration
-
Current Company
Dianthus Therapeutics Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2025 | Dianthus Therapeutics Inc | Independent Director | - | - |
| 2024 | Spyre Therapeutics Inc. | Independent Director | - | - |
| 2024 | Apogee Therapeutics Inc. | Independent Director | - | - |
| 2024 | Viridian Therapeutics Inc | Chairman of the Board | - | - |
| 2024 | Zenas Biopharma Inc. | Independent Director | - | - |
| 2023 | Apogee Therapeutics Inc. | Independent Director | 662.8 K | - |
| 2023 | Viridian Therapeutics Inc | Chairman of the Board | 503.8 K | 162.0 % |
| 2023 | Aeglea BioTherapeutics Inc | Director | - | - |
| 2023 | Dianthus Therapeutics Inc | Independent Director | - | - |
| 2023 | Spyre Therapeutics Inc. | Director | - | - |
| 2022 | Viridian Therapeutics Inc | Chairman of the Board | 192.3 K | -69.9 % |
| 2022 | Apogee Therapeutics Inc. | Independent Director | - | - |
| 2022 | Dianthus Therapeutics Inc | Director | - | - |
| 2021 | Viridian Therapeutics Inc | Chairman of the Board | 639.3 K | 2983.3 % |
| 2020 | Viridian Therapeutics Inc | Director | 20.7 K | - |